- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gail Wilensky: Senate Health Bill Will Be to the Left of the House
While there is a lot of uncertainty about what the final Senate healthcare reform bill will look like, Gail Wilensky, PhD, of Project HOPE, expects the bill will ultimately be to the left of the House bill in order to get the moderates on board.
While there is a lot of uncertainty about what the final Senate healthcare reform bill will look like, Gail Wilensky, PhD, of Project HOPE, expects the bill will ultimately be to the left of the House bill in order to get the moderates on board.
Transcript
What is your best prediction for what sort of healthcare legislation the Senate might end up passing (regardless of whether or not it can pass the House)?
My expectation is that they will be a little gentler on the changes to Medicaid than the House were. Not so much about moving to a per capita block grant; I think that can be justified if you had the proper baseline, and you had the proper growth rates, but you can’t take $880 billion out of the program and not do serious damage.
My assumption has been that the Senate legislation is to the left of the House because of the need to make sure the moderates stayed on board, but the conservatives are also pushing to not, in fact, undo the substantial reductions from Medicaid, and their participation is very important as well. So I’m not quite sure where the Senate is going to end up. When you have a 52 to 48 vote—and at the moment it doesn’t look like there’s going to be any bipartisan support on this package at least—it means you can only afford to lose 2 members and after that you’re in serious trouble.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Study Highlights Disparities in Access to In-Network Mental Health Care vs Medical Care
April 17th 2024While health plans often employ reimbursement rates as a tool to incentivize provider participation within their networks, study results showed reimbursement rates for office visits with medical/surgical clinicians were on average 22% higher than behavioral health clinicians.
Read More
